Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Antiatherogenic activity of antioxidant BO-653 explored in animal models

Oct. 13, 1998

Antiatherosclerotic compounds prepared by Bayer scientists

Oct. 13, 1998

Verelan and Verelan PM licensed to Schwarz for U.S.

Oct. 9, 1998

European academic researchers disclose nonxanthine adenosine receptor antagonists

Oct. 9, 1998

Endothelin antagonists for hypertension in development at Tanabe Seiyaku

Oct. 9, 1998

Long-term ETA receptor blockade shows detrimental effects on LV remodeling

Oct. 8, 1998

Dual TxA2 antagonists and NO donors and their use disclosed by ADIR

Oct. 8, 1998

Inex, Schwarz drop development of antisense drug for restenosis

Oct. 5, 1998

IRL-3630, a bifunctional ETA/ETB receptor antagonist in preliminary testing at Novartis

Oct. 2, 1998

Glaxo Wellcome's MMP inhibitor shows potential in treating sepsis in early clinical study

Oct. 2, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...